Barrons just reviewed the Rite Aid update Cold-remedy sales have slumped because of Covid-19 guidelines, but vaccinations now and the possibility of boosters later brighten the outlook.
Next week could be very good for Rite Aid as vaccine supply is now arriving in impressive volumes of vaccine are now being shipped to pharmacies and their warehouses.
Added at $18.70. Hope the shorts take it lower for my next add.
News 
Market Data 
Discover 
